CORC  > 厦门大学  > 生命科学-已发表论文
Frequency dependent prolongation of effective refractory period by a complex class III antiarrhythmic agent CPU-86017
Li, H. T. ; Wang, Y. Q. ; Dai, D. Z. ; Kong, R. Z. ; Wang YQ(王义权)
2001
关键词CPU-86017 myocardium lorcainide dofetilide verapamil amiodarone antiarrhythmic agents papillary muscles
英文摘要AIM: To compare the prolongation of the effective refractory period (ERP) of a novel complex Class III agent CPU-86017 with compounds blocking I-Na (lorcainide, Lor), I-K (dofetilide, Dof), I-Ca (verapamil, Ver) and a complex Class III multiple channel blocking agent (amiodarone, Ami) at different frequency levels. METHODS: The ERP of the guinea pig right papillary muscle and the anoxic left atrial muscle treated with high K+ at pH 6.6 - 6.8, in concentrations ranging 0.03 - 30 mu mol/L was compared at frequency levels ranging from 0.5 - 4.0 Hz. RESULTS: CPU-86017 showed a positive frequency dependence (PFD) with respect to ERP in the papillary muscles and a mild reverse frequency dependence(RFD) in the diseased atrium. The potency of ERP prolonging effect of various agents at 4.0 Hz was Dof > CPU-86017 > Ver > Ami > Lor, and Dof > CPU-86017 > Ami > Lor > Ver in the normal papillary and diseased atrial muscle, respectively. CONCLUSION: The profile and potency of prolonging the ERP by CPU 86017 is similar to Dof which blocks I-Kr in the diseased atrium, and to Ver which blocks I-Ca in guinea pig ventricle.
语种英语
内容类型期刊论文
源URL[http://dspace.xmu.edu.cn/handle/2288/65385]  
专题生命科学-已发表论文
推荐引用方式
GB/T 7714
Li, H. T.,Wang, Y. Q.,Dai, D. Z.,et al. Frequency dependent prolongation of effective refractory period by a complex class III antiarrhythmic agent CPU-86017[J],2001.
APA Li, H. T.,Wang, Y. Q.,Dai, D. Z.,Kong, R. Z.,&王义权.(2001).Frequency dependent prolongation of effective refractory period by a complex class III antiarrhythmic agent CPU-86017..
MLA Li, H. T.,et al."Frequency dependent prolongation of effective refractory period by a complex class III antiarrhythmic agent CPU-86017".(2001).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace